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Abstract 
Background: Some studies have shown that there is a correlation 
between serum uric acid and blood glucose levels so that these changes 
are not exactly clear. This study was conducted to determine the 
relationship between uric acid and blood glucose in diabetic patients. 
Methods: This cross-sectional study was performed on 190 type 2 
diabetic (DM) patients in Shahroud by convenience sampling method. 
FBS, uric acid, triglyceride, and total cholesterol under standard 
conditions were measured. Patients were divided into four groups in 
terms of uric acid level. 
Results: In this study, 53.7% of patients were male. The average age of 
cases was 58.3 ± 13.5 years. There was a significant difference in uric 
acid between age groups (Pvalue<0.023), educational levels 
(Pvalue<0.041), BMI (Pvalue<0.012) and cholesterol (Pvalue<0.002) 
groups. Also, there was a significant reverse relationship between 
mean FBS (Pvalue<0.001), blood glucose two hours after feeding 
(Pvalue<0.001), and HbA1c (Pvalue<0.02) with different levels of uric 
acid. 
Conclusions: The results showed that there was a significant and 
reversal relationship between the levels of uric acid and glucose levels. 
In order to control the level of uric acid, the level of glucose in these 
patients is also to be measured and controlled. 
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Introduction 
Uric acid is synthesized in the liver and is the final product 
of purine metabolism and purine produced in the human body.1 
Some studies have suggested that increase uric acid can cause 
hypertension, heart disease, and kidney disease.1-3 It can also 
cause peripheral arteries and metabolic syndrome.4 According 
to the world health organization, the global outbreak of 
diabetes in 2014 is estimated to be around 9% among adults 
over the age of 18 years, which will double by 2030.5 
According to the international foundation for the prevention 
and control of diabetes report in 2006, about 4 million Iranians 
suffer from diabetes, 90% of whom have type II diabetes.6 
Diabetes mellitus is a group of metabolic disorders that is the 
main and common sign of hyperglycemia. Hyperglycemia in 
diabetes due to insulin secretion defects, insulin function and, 
more commonly, both. The current criteria for the diagnosis of 
diabetes mellitus are on fasting sugar.6-7 Double-fasting glucose 
levels above 126 mg/dl suggest a diagnosis of diabetes 
mellitus. In addition, the impaired glucose tolerance test with 
75 gr of glucose in two steps, also suggests the diagnosis of 
diabetes. Serum uric acid is associated with oxidative stress and 
tumor necrosis factor α that both of which contribute to the 
development of diabetes. Uric acid is a possible biomarker in 
the worsening of glucose metabolism.8-9 The exact relationship 
between uric acid and blood glucose levels is unclear. Some 
studies, like the burns study, have shown an inverse 
relationship between uric acid and diabetes with a possible 
mechanism of uric acid absorption in proximal kidney tubes in 
diabetic patients,10 and some studies have shown no relation 
between them or even direct communication between them.11-13 
Due to the high prevalence of sugar metabolism disorders, also 
important to discover the factors associated with this disorder 
and not conducting related studies at the district level, the aim 
of this study was to investigate the relationship between uric 
acid and blood glucose in diabetic patients. 
Materials and Methods  
This cross-sectional study was performed on 190 DM 
patients admitted to Imam Hossein hospital in Shahroud during 
October 2016 till November 2017, who were selected by 
convenience sampling method. A blood sample was collected 
from all patients and was measured FBS, uric acid, triglyceride, 
and total cholesterol under standard conditions and was taken 
systolic and diastolic blood pressure (the measurement was 
done twice with a 10 minutes’ interval and mean of two 
measurements was calculated). Serum glucose was measured 
using the modified hexokinase method at the Imam Hossein 
hospital laboratory. Diabetes was defined based on the 
guidelines of the American diabetes association as a serum 
glucose≥126 mg/dL after fasting for a minimum of 8 hours, a 
serum glucose≥200 mg/dL for those who fasted<8 hours, or 
self-reported current use of oral hypoglycemic medication or 
insulin.14 Also serum uric acid measured using the SMA 
systems method. This technique has been commonly employed 
in automated hospital screening. This method depends on the 
reduction of a chromogen such as sodium tungstate by uric acid 
to produce a measurable color change.15-16 Age, gender, 
smoking status, level of education, history of diabetes and 
sugar controller drugs, antihypertensive drug use and BMI 
were assessed using a questionnaire. Serum total cholesterol 
was measured homogeneous assays versus.  
Serum uric acid level was categorized in four groups 
(<4.3 mg/dL, 4.30–5.20 mg/dL, 5.30–6.20 mg/dL, >6.20 mg/dL). 
According to the level of uric acid, patients were divided into two 
groups, normal) uric acid equal to and less than 5.3 mg/dl) and 
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non-normal (uric acid greater than 5.3 mg/dl). Then, 
independent variables with normal uric acid level (first and 
second uric acid subgroup) and abnormal (third and fourth uric 
acid subgroup) were evaluated in the multivariate regression model. 
The distribution of demographic and laboratory 
characteristics in terms of Uric acid levels was evaluated using 
Chi square test using SPSS (version 16.0) software. The 
significance level was set at 0.05. 
This study has an ethics code number 
(IR.SHMU.REC.1394.128) from the research deputy of Shahroud 
university of medical sciences. The essential information and the 
objectives of the study were explained to the patients, and written 
consent was obtained for participation in the plan. 
Results 
In this study, 102 cases (53.7%) were male and the rest were 
female. The mean age of patients was 58.3 ± 13.5 years. 
Subgroups of patients under study by categories of uric acid 
were showed in table 1. As it can be seen, there was a 
significant difference of uric acid between age groups 
(Pvalue<0.023), educational levels (Pvalue<0.041), BMI 
(Pvalue<0.012) and cholesterol groups (Pvalue<0.002), and 
there was no significant difference in other parameters. It was 
also found that there was a significant difference between mean 
scores of fasting blood sugar (Pvalue>0.001), blood glucose 
two hours after feeding (Pvalue<0.001), and HbA1c 
(Pvalue<0.02) in terms of different levels of uric acid, variation 
of the blood sugar by subgroups of uric acid was shown in table 
2 and figure 1. In this study, independent variables with 2 uric 
acid levels were investigated in multivariate regression model. 
As shown in table 3, age category, BMI, triglyceride level and 
total cholesterol level were significantly associated with the 
uric acid level change and there was no significant relationship 
with other variables. The results of the multivariate logistic 
regression model are presented in table 3. 
 
Table 1. Characteristics of patients under study by groups of uric acid level 
 
Characteristics 
Serum uric acid levels 
 
Pvalue 
<4.3 mg/dL 
(n=45) 
4.30–5.20 mg/dL 
(n=45) 
5.30–6.20 mg/dL 
(n=45) 
>6.20 mg/dL 
(n=45) 
Age  
 < 20 year 
 20-40 year 
 41-60 year 
 > 60 year 
 
12 (26.7%) 
19 (42.2%) 
8 (17.8%) 
6 (13.3%) 
 
12 (26.7%) 
15 (33.3%) 
8 (17.8%) 
10 (22.2%) 
 
8 (17.8%) 
17 (37.8%) 
10 (22.2%) 
10 (22.2%) 
 
5 (24.4%) 
15 (33.3%) 
14 (24.4%) 
11 (24.4%) 
 
<0.023 
Sex 
 Men 
 Women 
 
27(60%) 
18 (40%) 
 
25 (55.6%) 
20 (44.4%) 
 
26 (57.8%) 
19 (42.2%) 
 
28 (62.2%) 
17 (37.8%) 
 
0.102 
Education categories 
 Below diploma 
 Diploma  
 College education 
 
8 (17.8%) 
15 (33.3%) 
22 (48.9%) 
 
10 (22.2%) 
16 (35.6%) 
19 (42.2%) 
 
11 (24.4%) 
20 (44.4%) 
14 (31.1%) 
 
11 (24.4%) 
23 (51.1%) 
11 (24.4%) 
 
<0.041 
Smoking 
 Never smoker  
 Former smoker 
 Current smoker 
 
10 (22.2%) 
20 (44.4%) 
15 (33.3%) 
 
6 (13.3%) 
21 (46.7%) 
18 (40%) 
 
8 (17.8%) 
25 (55.6%) 
12 (26.7%) 
 
10 (22.2%) 
23 (51.1%) 
12 (26.7%) 
 
0.085 
BMI* (kg/m2) 
 Normal (≤ 24.99)  
 Overweight (25-29.99) 
 Obese (> 30) 
 
12 (26.7%) 
22 (48.9%) 
11 (24.4%) 
 
10 (22.2%) 
21 (46.7%) 
14 (31.1%) 
 
10 (22.2%) 
18 (40%) 
17 (37.8%) 
 
8 (17.8%) 
18 (40%) 
19(42.2%) 
 
<0.012 
Diabetic drug 
 Oral hypoglycemic 
 Insulin 
 
12 (26.7%) 
33 (73.3%) 
 
16 (35.6%) 
29 (64.4%) 
 
22 (48.9%) 
23 (51.9%) 
 
29 (64.4%) 
16 (35.6%) 
 
<0.065 
Antihypertensive drug   
 Positive 
 Negative 
 
16(35.6%) 
29 (64.4%) 
 
20 (44.4%) 
25 (55.6%) 
 
23 (51.9%) 
22 (48.9%) 
 
26 (57.8%) 
19 (42.2%) 
 
<0.077 
Triglyceride 
 ≤ 200 mg/dl 
 > 200 mg/dl 
 
32(71.1%) 
13 (28.9%) 
 
30 (66.7%) 
15 (33.3%) 
 
30 (66.7%) 
15 (33.3%) 
 
29 (64.4%) 
16 (35.6%) 
 
0.075 
Total cholesterol  
 ≤ 180 mg/dl 
 > 180 mg/dl 
 
25(55.6%) 
20 (44.4%) 
 
21 (46.7%) 
24 (53.3%) 
 
18 (40%) 
27 (60%) 
 
17 (37.8%) 
28 (62.2%) 
 
<0.002 
* BMI. Body mass index 
 
 
Table 2. Variation of the blood sugar by subgroups of uric acid level 
Variation 
Serum uric acid levels (mg/dL) 
Pvalue 
<4.3  4.30 – 5.20  5.30 – 6.20  >6.20  
Mean FBS (mg/dl) 192.13 ± 62.75 177.56 ± 53.71 158.25 ± 41.28 139.25 ± 35.45 P<0.001 
Mean 2hpp (mg/dl) 267.55 ± 68.23 249.39 ± 53.47 235.61 ± 51.25 226.84 ± 53.76 P<0.001 
Mean HbA1c (%) 7.8 ± 1.6 7.5 ± 1.7 7.1 ± 1.3 6.8 ± 1.4 P<0.02 
FBS. Fasting blood sugar; Mean 2hpp: Mean blood sugar after 2 hours; HbA1c: Glycated hemoglobin 
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Table 3. Relationship between independent variables with uric acid level greater than 5.3 mg / dl in multivariate logistic regression model 
Independent variables Odds ratio 95% Confidence Pvalue 
Age category    
 Less than 20 years 
 20 to 40 years 
 41 to 60 years 
 More than 60 years 
1.000 
1.089 
1.093 
1.123 
 
1.342 - 0.0652 
1.451 - 0.0712 
1.532 - 0.0857 
 
0.063 
0.052 
0.041 
Sex    
 Female 
 Male 
1.000 
1.098 
 
1.153 - 0.839 
 
0.069 
BMI* (kg/m2)    
 Normal (≤ 24.99) 
 Overweight (25 - 29.99) 
 Obese (> 30) 
1.000 
1.405 
1.823 
 
1.748 - 1.111 
2.324 - 1.557 
 
0.045 
0.001 
Education categories 
 Under the diploma 
 Diploma 
 College education 
1.000 
0.923 
0.875 
 
1.125 - 0.756 
1.035 - 0.612 
 
0.055 
0.051 
Smoking    
 Never smoker 
 Former smoker 
 Current smoker 
1.000 
1.105 
1.352 
 
1.384 - 0.927 
1.715 - 1.069 
 
0.093 
0.058 
Diabetic drug    
 Oral hypoglycemic 
 Insulin 
1.000 
1.118 
 
1.339 - 0.912 
 
0.077 
Antihypertensive drug    
 Negative 
 Positive 
1.000 
1.089 
 
1.263 - 0.916 
 
0.063 
Triglyceride    
 ≤ 200 mg/dl 
 > 200 mg/dl 
1.000 
1.478 
 
1.782 - 1.157 
 
0.039 
Total cholesterol    
 ≤ 180 mg/dl 
 > 180 mg/dl 
1.000 
2.831 
 
3.754 - 1.956 
 
0.001 
 
 
Figure 1. Association between serum uric acid level and fasting blood pressure 
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Discussion 
In some studies, there is a link between uric acid and DM, 
but this relationship has been limited to some factors such as 
sex.17 A number of studies have found this relationship very 
influential and relevant, while a number of other studies have 
reported no relation between uric acid and DM.18-19 It should be 
noted that even some studies have shown an inverse 
relationship between these two variables.20-21 The exact cause 
of all these differences in previous studies is not clear about the 
relationship between uric acid and diabetes but may be due to 
limitations in the study, such as selecting a specific population 
group, different methods of laboratory assessment or sample 
size.22 In a study by Kang et al., in 2002, with the aim of 
investigating the relationship between uric acid and fasting 
blood on 3632 individuals in China, serum uric acid levels in 
the non-diabetic subjects tended to increase with increasing 
FPG, but in diabetic patients, the newly diagnosed level of uric 
acid decreased, Which is in perfect agreement with our 
research results.22 
A study by Hostetter et al., in 2001 aimed at understanding 
the relationship between uric acid and various levels of blood 
glucose and related factors on 946 patients, it was concluded 
that the level of FBG and PPBG decreases with increased uric 
acid levels.23 This finding is consistent with our study results. 
One of the possible reasons that can justify this inverse 
relationship between uric acid and DM is the inhibition of uric 
acid reuptake by the kidneys due to high blood sugar levels in 
diabetic patients.24-25 This study found that even with control of 
factors such as age, sex, body mass index, cholesterol and 
triglyceride, there is an independent relationship between uric 
acid and blood glucose levels. This finding is consistent with 
the Brenner and Barnett researches results.26-27 The exact 
mechanism of the effect of uric acid on the amount of glucose 
is unknown, but speculation is being made in this area. 
Increasing the level of uric acid in the blood causes a change in 
the level of oxidative stress and systemic inflammation, both of 
which contribute to a change in blood glucose levels.3 On the 
other hand, changes in the amount of uric acid cause a change 
in the production of endothelial nitric oxide, which causes 
changes in the level of insulin resistance of the cells and also 
changes in blood glucose levels. Also, changes in the amount 
of uric acid cause changes in blood pressure in the kidney 
glomeruli and changes in sodium ion reabsorption from the 
kidneys, resulting in changes in blood insulin levels and, 
consequently, changes in blood glucose level.3,28  
Finally, the results of the study showed that there was a 
significant and reversal relationship between the levels of uric 
acid and glucose levels that with increasing the amount of uric 
acid, the amount of glucose is significantly reduced, but for 
more precise determination of this relationship, more studies 
and sample size are needed. The results of this study showed 
that there is an inverse relationship between uric acid and 
glucose in diabetic patients. Therefore, in order to control the 
level of glucose, the level of uric acid in these patients is also to 
be measured and controlled, but for more precise determination 
of this relationship, more studies and sample sizes are needed. 
The most important strength of the present study is the high 
sample size and population-based study, as well as the 
elimination of confounding factors through the multivariate 
regression model. The limitation of this project can be 
attributed to its cross-sectional nature, which makes it 
impossible to examine the relationship between changes in 
levels of uric acid and diabetes over time. More extensive 
studies, and especially Meta-analyzes, are essential for a 
thorough examination of the relationship between uric acid and 
diabetes. Finally, the results of this study showed that the 
amount of uric acid in the blood inversely affects blood glucose 
levels. 
Acknowledgement 
The present study was supported by Shahroud university of 
medical sciences. We hereby acknowledge the research deputy. 
Also we would like to thank all diabetic patients. 
Conflict of Interest 
The authors declare that they have no conflict of interest. 
References  
1. Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A. Effects 
of synbiotic food consumption on metabolic status of diabetic patients: a 
double-blind randomized cross-over controlled clinical trial. Clin Nutr 
2014;33:198-203. doi:10.1016/j.clnu.2013.05.015 
2. Kutoh E, Hori T. Effect of Pioglitazone on Serum Uric Acid levels in newly 
diagnosed, drug-naïve patients with type 2 Diabetes. Endocr Res 2013;38:151-
9. doi:10.3109/07435800.2012.745128 
3. Nielsen FS, Rossing P, Gall MA, Skott P, Smidt UM, Parving HH. Impact of 
lisinopril and atenolol on kidney function in hypertensive NIDDM subjects 
with diabetic nephropathy. Diabetes 1994;43:1108-13. 
doi:10.2337/diab.43.9.1108 
4. Momeni A, Shahidi S, Seirafian S, Taheri S, Kheiri S. Effect of allopurinol in 
decreasing proteinuria in type 2 diabetic patients. Iran J Kidney Dis 
2010;4:128-32. 
5. Saruta T. Effects of nicardipine on blood pressure and renal function in elderly 
hypertensive patients with renal dysfunction. Am Heart J 1989;117:243-9. 
doi:10.1016/0002-8703(89)90691-1 
6. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, et al. 
Prevalence of complications in IDDM by sex and duration. Pittsburgh 
epidemiology of Diabetes complications study II. Diabetes 1990;39:1116-24. 
doi:10.2337/diab.39.9.1116 
7. Pavkov ME, Knowler WC, Bennett PH, Looker HC, Krakoff J, Nelson RG. 
Increasing incidence of proteinuria and declining incidence of end-stage renal 
disease in diabetic Pima Indians. Kidney Int 2006;70:1840-6. 
doi:10.1038/sj.ki.5001882 
8. Hilgers KF, Veelken R. Type 2 diabetic nephropathy: never too early to treat? J 
Am Soc Nephrol 2005;16:574-5. doi:10.1681/ASN.2005010083 
9. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. 
Kidney Int 1999;56:393-405. doi:10.1046/j.1523-1755.1999.00590.x 
10. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, et al. 
Connective tissue growth factor plays an important role in advanced glycation 
end product-induced tubular epithelial-to mesenchymal transition: implications 
for diabetic renal disease. J Am Soc Nephrol 2006;17:2484-94. 
doi:10.1681/ASN.2006050525 
11. Adler S. Diabetic nephropathy: Linking histology, cell biology, and genetics. 
Kidney Int 2004;66:2095-106. doi:10.1111/j.1523-1755.2004.00988.x 
12. Tapp RJ, Shaw JE, Zimmet PZ, Balkau B, Chadban SJ, Tonkin AM, et al. 
Albuminuria is evident in the early stages of diabetes onset: results from the 
Australian Diabetes, obesity, and lifestyle study (AusDiab). Am J Kidney Dis 
2004;44:792-8. 
13. Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetic kidney 
disease in Pima Indians. Diabetes Care 1993;16:335-41. doi:10.2337/diacare.16.1.335 
14. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. 
Association between body mass index and CKD in apparently healthy men. 
Am J Kidney Dis 2005;46:871-80. doi:10.1053/j.ajkd.2005.08.015 
Amerian et al 
10       |        International Journal of Health Studies 2020;6(2)  
15. Tseng CH. Independent association of uric acid levels with peripheral arterial 
disease in Taiwanese patients with type 2 diabetes. Diabet Med 2004;21:724-9. 
doi:10.1111/j.1464-5491.2004.01239.x 
16. Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, 
Nepomuceno T, et al. Mild hyperuricemia induces vasoconstriction and 
maintains glomerular hypertension in normal and remnant kidney rats. Kidney 
Int 2005;67:237-47. doi:10.1111/j.1523-1755.2005.00074.x 
17. Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y, et al. Hyper 
uricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. 
Hypertens Res 2004;27:835-41. doi:10.1291/hypres.27.835 
18. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, et al. A role 
for uric acid in the progression of renal disease. J Am Soc Nephrol 
2001;13:2888-97. doi:10.1097/01.asn.0000034910.58454.fd 
19. Tseng CH. Correlation of uric acid and urinary albumin excretion rate in 
patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005;68:796-801. 
doi:10.1111/j.1523-1755.2005.00459.x 
20. Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G. Hypouricemia and 
hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 
2001;31:318-21. doi:10.1046/j.1365-2362.2001.00812.x 
21. Wun YT, Chan CS, Lui CS. Hyperuricaemia in Type 2 diabetes mellitus. 
Diabetes Nutr Metab 1999;12:286-91. 
22. Minami M, Ishiyama A, Takagi M, Omata M, Atarashi K. Effects of 
allopurinol, a xanthine oxidase inhibitor, on renal injury in 
hypercholesterolemia-induced hypertensive rats. Blood Press 2005;14:120-5. 
doi:10.1080/08037050510008878 
23. Hostetter TH. Prevention of end stage renal disease due to type 2 diabetes. N 
Engl J Med 2001;345:910-2. doi:10.1056/NEJM200109203451209 
24. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. 
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in 
patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-
60. doi:10.1056/NEJMoa011303 
25. Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Champion de 
Crespigny PJ, et al. Proteinuria reduction and progression to renal failure in 
patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 
2005;45:281-7. doi:10.1053/j.ajkd.2004.10.019 
26. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, 
et al. Effects of losartan on renal and cardiovascular outcomes in patients with 
type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9. 
doi:10.1056/NEJMoa011161 
27. Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, et al. 
Angiotensin-receptor blockade versus converting-enzyme inhibition in type II 
diabetes and nephropathy. N Engl J Med 2004;351:1952-61. 
doi:10.1056/NEJMoa042274 
28. Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric 
acid level and long-term incidence of hypertension: population-based cohort 
study. J Hum Hypertens 2006;20:937-45. doi:10.1038/sj.jhh.1002095 
 
